We stand in silence. We stand in solidarity. We stand for justice. We stand together! #StopViolenceAgainstDoctors #JusticeforKolkataDoctor #ReclaimTheNight #IMA #JusticeDelayedIsJusticeDenied #AIGHospitals

🏥 Highest burden of #LiverDisease is concentrated in the #Asia #Pacific Region ‼️ where 1/2 #cirrhosis 💀deaths and 3/4 of #LiverCancer #HCC deaths occur! Nature Reviews Gastroenterology & Hepatology 🆘Measures: - HBV vaccine - HCV DAA therapy - Alcohol policies - Betablockers for #PortalHypertension

Motion: Be it resolved that we will stop publishing that naltrexone is “contraindicated” in liver disease

In patients with #FattyLiver (#MASLD), the presence of #Diabetes and high visceral #fat (>15%) suggests a higher chance of significant #liver #fibrosis. This study involves over 600 patients with #NAFLD seen in our Fatty Liver Clinic. authors.elsevier.com/a/1je3u3TP1whB…

#TrendingNow *REVIEW Pancreatic cancer nature.com/articles/s4157… *REVIEW Functional constipation nature.com/articles/s4157… *REVIEW Liver disease & HCC in A-P region nature.com/articles/s4157… *REVIEW Proximal small intestine disorders nature.com/articles/s4157…

Throwback to last year's remarkable reception. Excited to see you all in San Diego for #TLM24! aasld.org/the-liver-meet…

Decompensated Cirrhotic with MELD 36 Prior H/o resection for CA rectum with diversion ileostomy Presents with HB drop UGI -Small Vx with No GOV Platelet -56 /INR-2.1 Possibilities -Sundeep Lakhtakia Anand V Kulkarni Sahaj Rathi MD, DM, MRCP Akash Roy Hardik Rughwani

Rapid review and quick decisions only Hepatology Communications led by Elliot Tapper & Prof. Carmen Wong Jeremy Louissaint #livertwitter

💥Acute-on-chronic liver failure ➡️Steps towards harmonization of the definition❗️ Expert Opinion by Anand V Kulkarni & Shiv Kumar Sarin Read it here👉journal-of-hepatology.eu/article/S0168-… #LiverTwitter

Long term outcomes of patients with HCV treated with DAA. Now Gastroenterology Congratulations M PREMKUMAR and Hepatology PGI #livertwitter

Opinion on steps for harmonization of ACLF definitions. Way forward !! #livertwitter

Important real-world data on Recompensation in #HCV post SVR12 ⬇️Decomp risk ❗HCC risk remained Check out Punjab-#HCV study by M PREMKUMAR Anand V Kulkarni Ajay Duseja The Baveno Cooperation: an EASL Consortium #portalhtn #cirrhosis #livertwitter

Excellent study of real world outcomes making a difference in patient lives and livers!

Introducing the 2024 Ashwani K. Singal Advanced/Transplant Hepatology Fellow Awardee! 🤩 Huge congrats to Hanna Blaney, MD, MPH. Learn more about AASLD Foundation's 2024 awardees at aasldfoundation.org/2024-research-…

Proud to present our latest guidelines: Diagnosis and management of pediatric acute liver failure: consensus recommendations of the Indian Society of Pedia… pubmed.ncbi.nlm.nih.gov/39212863/ Hepatology International ESPGHAN ILBS_University Ispghan

📢New editorial out! Is there a relationship between AKI and alcohol-associated hepatitis? Grateful to have co-authored, under the guidance of Rakhi Maiwall .Let's solve the puzzle 🧩Read: doi.org/10.1111/apt.18… ILBS_University Anand V Kulkarni #livertwitter

New Comment - Blaney et al - Global differences in the management of alcohol-associated hepatitis thelancet.com/journals/langa… #LiverTwitter Juan Pablo (JP) Arab, MD  Elliot Tapper Ramon Bataller Anand V Kulkarni Luis Antonio Díaz, MD

Just out! Is AlcHep treated the same everywhere? No, not at all. See the main similarities and differences here. Great job by Hanna Blaney, MD, MPH! #LiverTwitter #LiverX Elliot Tapper Luis Antonio Díaz, MD Anand V Kulkarni

Succinct article highlighting important 🌎 practice patterns in managing 🍻 hepatitis: 📌Large variability across practice settings and regions 📌Global inequities in availability of LT for AAH Kudos to this all-star team, including Hanna Blaney, MD, MPH Juan Pablo (JP) Arab, MD  Anand V Kulkarni